Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0000950170-25-032141

VP, Chief Accounting Officer acquired 14,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dube Michael P VP, Chief Accounting Officer 2025-03-01 Grant or award +14,000 59,640 D: show line 1 in the form
Loading xslF345X05/ownership.xml…